News | Mammography | October 21, 2015

New American Cancer Society Guidelines Recommend Annual Mammograms Beginning at 45

Guidelines also recommend biennial screening for women 55 and older, with overall goal to reduce false positives

American Cancer Society, ACS, breast cancer screening guidelines, annual mammography, age 45

October 21, 2015 – An updated breast cancer screening guideline from the American Cancer Society (ACS) recommends that women at average risk start regular annual mammography screening at age 45 and transition to screening every two years starting at age 55. The guideline supports informed decision-making for women ages 40 to 44, who should have the option to begin screening early, and for women 55 and older, who should have the opportunity to continue screening every year if they choose. It is being published in the Journal of the American Medical Association.

The guideline is the first created since the ACS incorporated Institute of Medicine standards into its guideline development protocol to ensure a more rigorous and transparent process for developing and communicating guidelines.

“These recommendations are made with the intent of maximizing reductions in breast cancer mortality and years of life saved while being attentive to the need to minimize harms associated with screening,” said Kevin Oeffinger, M.D., chair of the breast cancer guideline panel and a family physician at Memorial Sloan Kettering Cancer Center. “The benefits, burdens and judgment about that balance differ depending on a woman’s age, health, values and preferences. These recommendations recognize and reflect those differences.”

The guideline recommends:

  • All women should become familiar with the potential benefits, limitations and harms associated with breast cancer screening;
  • Women with an average risk of breast cancer should undergo regular screening mammography starting at age 45 (strong recommendation);
    • Women who are 45 to 54 years old should be screened annually (qualified recommendation);
    • Women who are 55 and older should transition to biennial screening or have the opportunity to continue screening annually (qualified recommendation);
    • Women should have the opportunity to begin annual screening between the ages of 40 and 44 (qualified recommendation);
  • Women should continue screening as long as their overall health is good and they have a life expectancy of 10 years or more (qualified recommendation); and
  • The ACS does not recommend clinical breast examination for breast cancer screening among average-risk women at any age (qualified recommendation).

A strong recommendation conveys the consensus that the benefits of adherence to that intervention outweigh the undesirable effects that may result from screening.

Qualified recommendations indicate there is clear evidence of benefit of screening but less certainty about the balance of benefits and harms, or about patients’ values and preferences, which could lead to different decisions about screening.

 “This guideline relies on the best evidence to offer new, more precise guidance taking into account a woman’s age, health, and personal values and preferences.” said Elizabeth "Terry" Fontham, founding dean of the School of Public Health at Louisiana State University (LSU) Health Sciences Center in New Orleans and chair of the ACS Guideline Development Group (GDG). “Though the evidence shows that there are some benefits from mammography screening starting at age 40, those benefits more clearly outweigh the harms from age 45 onward. Still, some women will choose to begin screening between age 40 and 44, both because they are concerned about their risk of breast cancer, either in general or because they are at higher risk, and are less concerned about the chances of experiencing a false positive findings.  Those women should have the opportunity to start screening at 40 if they choose.”

The guideline was developed by the GDG, a panel of generalist clinicians, biostatisticians, epidemiologists, economists and patient representatives convened by the American Cancer Society. The GDG commissioned a systematic review of the evidence by an independent center, the Duke University Evidence Synthesis Group, to inform the recommendations process.

Based on that evidence review, the panel concluded that there is a benefit from screening with mammography for women in their early 40s, but that risk is lower and harms, primarily from false positives, are somewhat greater for women ages 40-44 than for women in older age groups. Nonetheless, the GDG recognized that some women will choose to accept the harms from screening as a reasonable trade-off for the benefits.

“The option to screen every two years for women beginning at age 55 is based on the fact that post-menopausal breast cancers tend to develop more slowly,” said Oeffinger. “Because of that, women may choose either to continue annual screening or move to screening every two years beginning at age 55. Breast cancers before menopause tend to grow more rapidly, making screening every year important.”

The panel notes that efforts are underway to reduce false positives, including studies to improve the quality of mammography interpretation. Tomosynthesis, also known as 3-D mammography, may also improve outcomes while reducing false positives, but there was too little data at the time the evidence review was initiated to include comparisons with 2-D mammography. Molecular biomarkers may also help better predict progression, lessening the likelihood of overtreatment. The panel also noted that barriers still exist that prevent many low-income, uninsured women or those without a usual source of care from having access to high-quality screening.

The evidence review also found a lack of evidence showing benefit from routine clinical breast exams (CBE), and moderate evidence that doing CBE along with mammography increases the rate of false positives. Based on this information, the GDG did not recommend CBE. Still, the new recommendation does not discount the potential for CBE to be valuable in low resource settings outside the United States where mammography screening is not feasible.

For more information: www.cancer.org

Related Content

Breast Cancer Follow-up Imaging Varies Widely
News | Breast Imaging | July 13, 2018
July 13, 2018 — Follow-up imaging for women...
Invision Diagnostics Installs VolparaEnterprise Software to Enhance Mammography Image Quality
News | Mammography | July 11, 2018
Invision Diagnostics, a provider of mobile mammography services across North and South Carolina, announced that it is...
Breast Cancer Studies Ignore Race, Socioeconomic Factors
News | Women's Health | July 11, 2018
A new commentary appearing in the July issue of Cancer Causes & Control points to evidence that social factors help...
Hologic Announces Availability of Viera Portable Breast Ultrasound System
Technology | Ultrasound Women's Health | July 11, 2018
Hologic’s new Viera portable breast ultrasound system is now available for purchase in the United States and Europe....
Jeffrey Hoffmeister, M.D.

Jeffrey Hoffmeister, M.D.

Feature | Breast Imaging | July 05, 2018 | By Jeffrey Hoffmeister, M.D.
When women reach age 40, an annual mammogram becomes a necessary part of their healthcare ritual — regardless if they...
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
Norwegian Study Confirms Higher Cancer Rate in Women with Dense Breast Tissue
News | Breast Density | July 02, 2018
A large Norwegian study using automated breast density measurements found that women with mammographically dense breast...
3-D Imaging and Computer Modeling Capture Breast Duct Development

An image of a developing mammary duct. Image courtesy of Andrew Ewald.

News | Breast Imaging | June 28, 2018
A team of biologists has joined up with civil engineers to create what is believed to be the first 3-D computer model...
FDA Article Underscores Benefits of Adequate Breast Compression for Mammography Image Quality
News | Mammography | June 26, 2018
Inadequate breast commission played a role in up to 38 percent of mammogram image quality deficiencies, according to a...
Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
Overlay Init